Ilia Belotserkovsky

Dr. Ilia Belotserkovsky


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
IBIlia Belotserkovsky
Ilia Belotserkovsky
CVCecile Vernochet
Cecile Vernochet
BBBenoit Beitz
Benoit Beitz
BABouthaina Ben Abdallah
Bouthaina Ben Abdallah
SPSophiane Poissonier
Sophiane Poissonier
CVChristophe Vedrine
Christophe Vedrine
Severe acute malnutrition is associated with enteropathy manifested as disruption of epithelial tight junctions and increased gut permeability, associated with intestinal and systemic inflammation. Bifidobacterium longum subsp. infantis (B. infantis) and Lacticaseibacillus rhamnosus GG (LGG ®, Chr. Hansen A/S) have been shown to strengthen the gut epithelial barrier and to reduce inflammation in preclinical studies. The aim of this study was to compare the ability of four commercial strains of B. infantis, LGG and their combination to mitigate inflammation-mediated epithelial damage using an in-vitro immunocompetent model of the intestine. A microfluidic mid-throughput device OrganoPlate® (Mimetas B.V.) was employed to enable the co-culturing of intestinal epithelial cells (Caco-2) with peripheral blood mononuclear cells. Epithelial damage was induced by stimulating PBMCs with lipopolysaccharide and probiotic conditioned media were added to the apical side of the Caco-2 to test the effects on barrier integrity, cytokine secretion, and gene transcription. All tested probiotics demonstrated significant protection of the epithelium via modulation of tight-junction proteins and homeostatic cytokines gene transcription promoting a “leak-tight” phenotype. These findings demonstrate that B. infantis and/or LGG may have the potential to protect the intestinal epithelium and thus could contribute to alleviating intestinal enteropathy in malnourished children.

19 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
NCNaomi Canourgues
Naomi Canourgues
EAEmilie Adicéam
Emilie Adicéam
BBBenoit Beitz
Benoit Beitz
SAScott Xavier Atwell
Scott Xavier Atwell
MRMaroussia Roelens
Maroussia Roelens
IBIlia Belotserkovsky
Ilia Belotserkovsky
The intestinal microbiota and immune system are separated by an epithelial layer, whose barrier function is crucial for the healthy state of the host, while its impairment, usually associated with inflammation, leads to a variety of pathologies in humans. Different probiotics targeting the preservation of epithelial barrier homeostasis are thus currently being developed. Their selection and validation are a complex process involving in-vitro and in-vivo models. While the former lacks the complexity of the physiological system, the latter often fails to reflect the effect in humans. We used the commercial microfluidic high-throughput device OrganoPlate to set up a Gut-on-Chip model comprising human epithelial and peripheral blood mononuclear cells (PBMC). As a proof-of-concept, we co-cultured several intestinal anaerobic bacteria species in direct contact with the epithelial monolayer for two days to investigate their impact on epithelial barrier integrity and immune response upon induction of inflammation. We demonstrate here that Bacteroides thetaiotaomicron protects the epithelial barrier and dampens CCL2 secretion provoked by LPS-stimulated PBMC. Recapitulating the key features of intestinal inflammation, we suggest that the current Gut-on-Chip model enables an easy-to-use screen of next-generation probiotics and live biotherapeutics with homeostatic and immunomodulatory properties.

25 March 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SBSamuel Bellais
Samuel Bellais
MNMélanie Nehlich
Mélanie Nehlich
ADAurore Duquenoy
Aurore Duquenoy
MAMaryne Ania
Maryne Ania
GEGer van Den Engh
Ger van Den Engh
VTVincent Thomas
Vincent Thomas
Background: There is a growing interest in using gut commensal bacteria as ‘next generation’ probiotics. However, this approach is still hampered by the fact that there are few or no strains available for specific species that are difficult to cultivate. Our objective was therefore to adapt flow cytometry and cell sorting to be able to detect, separate, isolate and cultivate new strains of Extremely Oxygen Sensitive (EOS) species from fecal material, focusing on Faecalibacterium prausnitzii as a proof-of-concept. Results: A BD Influx ® cell sorter was equipped with a glovebox that covers the sorting area. This box is flushed with nitrogen to deplete oxygen in the enclosure. Several non-specific staining methods including Wheat Germ Agglutinin (WGA), Vancomycin BODIPY™ and LIVE/DEAD BacLight were evaluated with three different strains of the EOS species F. prausnitzii . In parallel, we generated polyclonal antibodies directed against this species by immunizing rabbits with heat-inactivated bacteria. Anaerobic conditions were maintained during the full process, resulting in only minor viability loss during sorting and culture of unstained F. prausnitzii reference strains. In addition, staining solutions did not severely impact bacterial viability while allowing discrimination between groups of strains. Efficient detection was achieved using polyclonal antibodies directed against heat-fixed bacteria. Finally, we were able to detect, isolate and cultivate a variety of F. prausnitzii strains from healthy volunteer’s fecal samples using WGA staining and antibodies. These strains present markedly different phenotypes, thus confirming the heterogeneity of the species. Conclusions: Cell-sorting in anaerobic conditions is a promising tool for the study of fecal microbiota. It gives the opportunity to quickly analyze microbial populations and to sort strains of interest using specific antibodies, thus opening new avenues for targeted culturomics experiments.